Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

WEST CHESTER, PA– Dec. 23, 2020 (GLOBE NEWSWIRE)– Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news